A double-blind, multicentre, stratified by centre, randomised, parallel study with two groups of adult patients operated on for Crohn's disease, to determine if oral ingestion of probiotics could prevent the appearance of Crohn's disease recurrent endoscopic ileo-colonic lesions 12 months after surgery. Patients will consume 900 mg/day of active product (N=56) or control product (N=56) during one year.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
DOUBLE
Enrollment
122
1- 6 test products/day
2- 6 control poducts/day
Hôpital Huriez - Service des maladies de l'appareil digestif et de la nutrition
Lille, France
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.